Research & Development



  果然,雲瑯的話音剛落,何愁有就出現在窗外,他指著遠去的郭解道︰“這人不是你們一伙的?”   雲瑯沒動彈,因為他看見一顆明光 亮的禿頭從石頭堆上升起,然後,他就看見一張似笑非笑的臉。啪啪   阿嬌臉色大變,一把捂住劉徹的嘴巴厲聲道︰“不許胡說,再這麼說下去,妾身早就該丟八十回蠆盆。”啪啪啪视频   自從看到了那張漢人臉,加上听到了純正的長安話,雲瑯的心就更加的穩定。   長平並不願意輕易地將皇家秘聞說給張氏听,畢竟,何愁有這種人的存在,對皇家來說談不到體面。超碰在线   太祖高皇帝叫過戚夫人,指著他們的背影說︰“我本想更換太子,但是有他們四人輔佐,看來太子羽翼已成,難以動他了。呂雉這回真是你的主人了!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo